Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | GNPAT | O15228 | 2/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.37 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232125 | 1.00 | FOLH1 (0.51) | FOLH1SLC6A5GNPATCPB2NOD1 | |
| SCHEMBL867577 | 1.00 | FOLH1 (0.51) | FOLH1SLC6A5GNPATCPB2NOD1 | |
| Hydrochloric Acid SCHEMBL1982441 | 0.98 | FOLH1 (0.50) | FOLH1SLC6A5GNPATCPB2NOD1 | |
| Hydrochloric Acid SCHEMBL1982438 | 0.98 | FOLH1 (0.50) | FOLH1SLC6A5GNPATCPB2NOD1 | |
| SCHEMBL45765 | 0.95 | FOLH1 (0.58) | FOLH1SLC6A5GNPATCPB2GSR | |
| SCHEMBL214641 | 0.95 | FOLH1 (0.58) | FOLH1SLC6A5GNPATCPB2GSR | |
| Hydrochloric Acid SCHEMBL2166126 | 0.93 | FOLH1 (0.57) | FOLH1SLC6A5GNPATCPB2GSR | |
| Acetic Acid SCHEMBL268740 | 0.93 | FOLH1 (0.57) | FOLH1SLC6A5GNPATCPB2GSR | |
| Hydrochloric Acid SCHEMBL15914484 | 0.93 | FOLH1 (0.57) | FOLH1SLC6A5GNPATCPB2GSR | |
| SCHEMBL159460 | 0.85 | GNPAT (0.55) | FOLH1SLC6A5GNPATCPB2NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4447916-A1 | HAIR CONDITIONING COMPOSITION | The Procter & Gamble Company (US) | 2024-10-23 | — | — | EP | claimed |
| WO-2023114680-A1 | HAIR CONDITIONING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-22 | — | — | WO | claimed |
| US-20230190601-A1 | HAIR CONDITIONING COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2023-06-22 | — | — | US | claimed |
| US-20120076859-A1 | Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases | ACTIVAERO GMBH (DE) | 2012-03-29 | — | — | US | claimed |
| WO-2025122600-A1 | COMPOSITIONS AND METHODS FOR TREATING ABERRANT NITROSYLATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2025-06-12 | — | — | WO | disclosed |
| EP-4447916-A1 | HAIR CONDITIONING COMPOSITION | The Procter & Gamble Company (US) | 2024-10-23 | — | — | EP | disclosed |
| CN-118317761-A | Hair conditioning composition | 宝洁公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20230190601-A1 | HAIR CONDITIONING COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2023-06-22 | — | — | US | disclosed |
| WO-2023114680-A1 | HAIR CONDITIONING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20180161376-A1 | COMPOSITIONS AND METHODS FOR NEURONAL DIFFERENTIATION OF CELLS | NORTHERN SYDNEY LOCAL HEALTH DISTRICT (AU) | 2018-06-14 | — | — | US | disclosed |
| EP-2308510-B1 | Agent for regeneration and/or protection of nerves | ONO PHARMACEUTICAL CO (JP) | 2016-03-16 | — | — | EP | disclosed |
| CN-104940126-A | Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders | OTONOMY INC | 2015-09-30 | — | — | CN | disclosed |
| EP-0750906-A1 | DELTA-(S-METHYLISOTHIOUREIDO)-L-NORVALINE AND CEREBROVASCULAR DISORDER REMEDY HAVING NITROGEN MONOXIDE SYNTHASE INHIBITOR ACTIVITY | Chugai Seiyaku Kabushiki Kaisha (JP) | 1997-01-02 | — | — | EP | disclosed |
| EP-0718294-A1 | 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-26 | — | — | EP | disclosed |
| EP-0713704-A1 | 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-05-29 | — | — | EP | disclosed |
| EP-0603335-A4 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE. | US HEALTH (US) | 1995-07-05 | — | — | EP | disclosed |
| WO-1994023038-A1 | INDUCIBLE NITRIC OXIDE SYNTHASE AND GENE THEREFOR | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
| EP-0603335-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-06-29 | — | — | EP | disclosed |
| US-5225440-A | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-07-06 | — | — | US | disclosed |
| WO-1993005775-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-04-01 | — | — | WO | disclosed |